TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novartis Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
192,340
|
178,091
|
156,689 |
| Financial expenses |
1,563
|
1,091
|
821 |
| Earnings before taxes |
7,301
|
5,117
|
5,551 |
| EBITDA |
9,082
|
6,364
|
6,613 |
| Total assets |
90,595
|
66,911
|
62,828 |
| Current assets |
89,461
|
65,661
|
61,485 |
| Current liabilities |
32,768
|
30,745
|
29,127 |
| Equity capital |
13,134
|
11,885
|
8,995 |
| - share capital |
435
|
451
|
449 |
| Employees (average) |
142
|
189
|
206 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
14.5%
|
17.8%
|
14.3% |
| Turnover per employee |
1,355
|
942
|
761 |
| Profit as a percentage of turnover |
3.8%
|
2.9%
|
3.5% |
| Return on assets (ROA) |
9.8%
|
9.3%
|
10.1% |
| Current ratio |
273.0%
|
213.6%
|
211.1% |
| Return on equity (ROE) |
55.6%
|
43.1%
|
61.7% |
| Change turnover |
20,303
|
20,946
|
8,702 |
| Change turnover % |
12%
|
13%
|
6% |
| Chg. No. of employees |
-47
|
-17
|
-10 |
| Chg. No. of employees % |
-25%
|
-8%
|
-5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.